News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Coridea Out to Prove Devices Can Replace Drugs - and Succeeding


12/10/2012 9:03:52 AM

The burning question of the biopharma industry over the last several years is “where are the new drugs?” With blockbusters going off patent and investigational drugs failing in clinical trial after clinical trial, there has been a dearth of important new medications, and venture capital financing in life sciences startups has dropped like a stone. A cardiologist and an engineer believe they have found a better way, however, to move life sciences forward—with innovations that treat or cure diseases without new drugs. Mark Gelfand and Howard Levin, co-founders of New York-based technology incubator Coridea, believe that now is a golden age, not for drugs, but for medical devices. “Drugs are shotguns that hit a lot of targets, and create a lot of side effects as a result,” says Levin, the cardiologist. “Medical devices tend to be snipers. A [heart] valve replacement fixes one specific problem, and that’s it. No worries about side effects.” Plus, he says, unlike many drugs that must be taken for life, devices can often cure diseases, making them much more appealing to patients, and to payers.

Read at Xconomy


comments powered by Disqus
Xconomy
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES